ID   PRRT2_HUMAN             Reviewed;         340 AA.
AC   Q7Z6L0; A8K8M8; Q8N2N8; Q8NAQ7; Q8ND36; Q96FA8;
DT   23-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2003, sequence version 1.
DT   10-MAY-2017, entry version 110.
DE   RecName: Full=Proline-rich transmembrane protein 2;
DE   AltName: Full=Dispanin subfamily B member 3;
DE            Short=DSPB3;
GN   Name=PRRT2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Teratocarcinoma, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Embryo;
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-
RT   length human cDNAs encoding secretion or membrane proteins from oligo-
RT   capped cDNA libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INVOLVEMENT IN EKD1, SUBCELLULAR LOCATION, AND VARIANTS ALA-138;
RP   HIS-147; PRO-214; ARG-237 AND HIS-245.
RX   PubMed=22101681; DOI=10.1038/ng.1008;
RA   Chen W.J., Lin Y., Xiong Z.Q., Wei W., Ni W., Tan G.H., Guo S.L.,
RA   He J., Chen Y.F., Zhang Q.J., Li H.F., Lin Y., Murong S.X., Xu J.,
RA   Wang N., Wu Z.Y.;
RT   "Exome sequencing identifies truncating mutations in PRRT2 that cause
RT   paroxysmal kinesigenic dyskinesia.";
RL   Nat. Genet. 43:1252-1255(2011).
RN   [7]
RP   INVOLVEMENT IN BFIS2, VARIANT ICCA ASN-317, AND VARIANTS ARG-215 AND
RP   LEU-216.
RX   PubMed=22243967; DOI=10.1016/j.ajhg.2011.12.003;
RA   Heron S.E., Grinton B.E., Kivity S., Afawi Z., Zuberi S.M.,
RA   Hughes J.N., Pridmore C., Hodgson B.L., Iona X., Sadleir L.G.,
RA   Pelekanos J., Herlenius E., Goldberg-Stern H., Bassan H., Haan E.,
RA   Korczyn A.D., Gardner A.E., Corbett M.A., Gecz J., Thomas P.Q.,
RA   Mulley J.C., Berkovic S.F., Scheffer I.E., Dibbens L.M.;
RT   "PRRT2 mutations cause benign familial infantile epilepsy and
RT   infantile convulsions with choreoathetosis syndrome.";
RL   Am. J. Hum. Genet. 90:152-160(2012).
RN   [8]
RP   INVOLVEMENT IN BFIS2.
RX   PubMed=22399141; DOI=10.1038/jhg.2012.23;
RA   Ono S., Yoshiura K.I., Kinoshita A., Kikuchi T., Nakane Y., Kato N.,
RA   Sadamatsu M., Konishi T., Nagamitsu S., Matsuura M., Yasuda A.,
RA   Komine M., Kanai K., Inoue T., Osamura T., Saito K., Hirose S.,
RA   Koide H., Tomita H., Ozawa H., Niikawa N., Kurotaki N.;
RT   "Mutations in PRRT2 responsible for paroxysmal kinesigenic dyskinesias
RT   also cause benign familial infantile convulsions.";
RL   J. Hum. Genet. 57:338-341(2012).
RN   [9]
RP   VARIANT EKD1 ARG-305.
RX   PubMed=22209761; DOI=10.1136/jmedgenet-2011-100653;
RA   Liu Q., Qi Z., Wan X.H., Li J.Y., Shi L., Lu Q., Zhou X.Q., Qiao L.,
RA   Wu L.W., Liu X.Q., Yang W., Liu Y., Cui L.Y., Zhang X.;
RT   "Mutations in PRRT2 result in paroxysmal dyskinesias with marked
RT   variability in clinical expression.";
RL   J. Med. Genet. 49:79-82(2012).
RN   [10]
RP   GENE FAMILY.
RX   PubMed=22363774; DOI=10.1371/journal.pone.0031961;
RA   Sallman Almen M., Bringeland N., Fredriksson R., Schioth H.B.;
RT   "The dispanins: a novel gene family of ancient origin that contains 14
RT   human members.";
RL   PLoS ONE 7:E31961-E31961(2012).
RN   [11]
RP   VARIANT EKD1 TRP-266.
RX   PubMed=22120146; DOI=10.1093/brain/awr289;
RA   Wang J.L., Cao L., Li X.H., Hu Z.M., Li J.D., Zhang J.G., Liang Y.,
RA   San A., Li N., Chen S.Q., Guo J.F., Jiang H., Shen L., Zheng L.,
RA   Mao X., Yan W.Q., Zhou Y., Shi Y.T., Ai S.X., Dai M.Z., Zhang P.,
RA   Xia K., Chen S.D., Tang B.S.;
RT   "Identification of PRRT2 as the causative gene of paroxysmal
RT   kinesigenic dyskinesias.";
RL   Brain 134:3493-3501(2011).
RN   [12]
RP   VARIANT BFIS2 GLU-323.
RX   PubMed=22623405; DOI=10.1002/humu.22126;
RA   Schubert J., Paravidino R., Becker F., Berger A., Bebek N.,
RA   Bianchi A., Brockmann K., Capovilla G., Bernardina B.D., Fukuyama Y.,
RA   Hoffmann G.F., Jurkat-Rott K., Antonnen A.K., Kurlemann G.,
RA   Lehesjoki A.E., Lehmann-Horn F., Mastrangelo M., Mause U., Muller S.,
RA   Neubauer B., Pust B., Rating D., Robbiano A., Ruf S., Schroeder C.,
RA   Seidel A., Specchio N., Stephani U., Striano P., Teichler J.,
RA   Turkdogan D., Vigevano F., Viri M., Bauer P., Zara F., Lerche H.,
RA   Weber Y.G.;
RT   "PRRT2 Mutations are the major cause of benign familial infantile
RT   seizures.";
RL   Hum. Mutat. 33:1439-1443(2012).
RN   [13]
RP   VARIANTS EKD1 ARG-281; THR-287 AND CYS-308.
RX   PubMed=22131361; DOI=10.1136/jmedgenet-2011-100635;
RA   Li J., Zhu X., Wang X., Sun W., Feng B., Du T., Sun B., Niu F.,
RA   Wei H., Wu X., Dong L., Li L., Cai X., Wang Y., Liu Y.;
RT   "Targeted genomic sequencing identifies PRRT2 mutations as a cause of
RT   paroxysmal kinesigenic choreoathetosis.";
RL   J. Med. Genet. 49:76-78(2012).
CC   -!- SUBUNIT: Component of the outer core of AMPAR complex. AMPAR
CC       complex consists of an inner core made of 4 pore-forming GluA/GRIA
CC       proteins (GRIA1, GRIA2, GRIA3 and GRIA4) and 4 major auxiliary
CC       subunits arranged in a twofold symmetry. One of the two pairs of
CC       distinct binding sites is occupied either by CNIH2, CNIH3 or
CC       CACNG2, CACNG3. The other harbors CACNG2, CACNG3, CACNG4, CACNG8
CC       or GSG1L. This inner core of AMPAR complex is complemented by
CC       outer core constituents binding directly to the GluA/GRIA proteins
CC       at sites distinct from the interaction sites of the inner core
CC       constituents. Outer core constituents include at least PRRT1,
CC       PRRT2, CKAMP44/SHISA9, FRRS1L and NRN1. The proteins of the inner
CC       and outer core serve as a platform for other, more peripherally
CC       associated AMPAR constituents. Alone or in combination, these
CC       auxiliary subunits control the gating and pharmacology of the
CC       AMPAR complex and profoundly impact their biogenesis and protein
CC       processing (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:22101681};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:22101681}. Cell
CC       junction, synapse {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q7Z6L0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q7Z6L0-2; Sequence=VSP_028815;
CC       Name=3;
CC         IsoId=Q7Z6L0-3; Sequence=VSP_028814;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Episodic kinesigenic dyskinesia 1 (EKD1) [MIM:128200]: An
CC       autosomal dominant neurologic condition characterized by recurrent
CC       and brief attacks of abnormal involuntary movements, triggered by
CC       sudden voluntary movement. These attacks usually have onset during
CC       childhood or early adulthood and can involve dystonic postures,
CC       chorea, or athetosis. {ECO:0000269|PubMed:22101681,
CC       ECO:0000269|PubMed:22120146, ECO:0000269|PubMed:22131361,
CC       ECO:0000269|PubMed:22209761}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry. Disease-
CC       causing mutations that produce truncation of the C-terminus of the
CC       protein alter subcellular location, from plasma membrane to
CC       cytoplasm (PubMed:22101681). {ECO:0000269|PubMed:22101681}.
CC   -!- DISEASE: Convulsions, familial infantile, with paroxysmal
CC       choreoathetosis (ICCA) [MIM:602066]: A syndrome characterized by
CC       clinical features of benign familial infantile seizures and
CC       episodic kinesigenic dyskinesia. Benign familial infantile
CC       seizures is a disorder characterized by afebrile seizures
CC       occurring during the first year of life, without neurologic
CC       sequelae. Paroxysmal choreoathetosis is a disorder of involuntary
CC       movements characterized by attacks that occur spontaneously or are
CC       induced by a variety of stimuli. {ECO:0000269|PubMed:22243967}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Seizures, benign familial infantile, 2 (BFIS2)
CC       [MIM:605751]: A form of benign familial infantile epilepsy, a
CC       neurologic disorder characterized by afebrile seizures occurring
CC       in clusters during the first year of life, without neurologic
CC       sequelae. BFIS2 inheritance is autosomal dominant.
CC       {ECO:0000269|PubMed:22243967, ECO:0000269|PubMed:22399141,
CC       ECO:0000269|PubMed:22623405}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the CD225/Dispanin family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Proline-rich transmembrane protein 2 (PRRT2);
CC       Note=Leiden Open Variation Database (LOVD);
CC       URL="http://www.lovd.nl/PRRT2";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK092265; BAC03843.1; -; mRNA.
DR   EMBL; AK074572; BAC11067.1; -; mRNA.
DR   EMBL; AK292393; BAF85082.1; -; mRNA.
DR   EMBL; AL834185; CAD38881.1; -; mRNA.
DR   EMBL; CH471238; EAW79991.1; -; Genomic_DNA.
DR   EMBL; BC011405; AAH11405.1; -; mRNA.
DR   EMBL; BC053594; AAH53594.1; -; mRNA.
DR   CCDS; CCDS10654.1; -. [Q7Z6L0-1]
DR   CCDS; CCDS58445.1; -. [Q7Z6L0-2]
DR   CCDS; CCDS58446.1; -. [Q7Z6L0-3]
DR   RefSeq; NP_001243371.1; NM_001256442.1. [Q7Z6L0-2]
DR   RefSeq; NP_001243372.1; NM_001256443.1. [Q7Z6L0-3]
DR   RefSeq; NP_660282.2; NM_145239.2. [Q7Z6L0-1]
DR   RefSeq; XP_011544017.1; XM_011545715.2. [Q7Z6L0-2]
DR   RefSeq; XP_011544018.1; XM_011545716.2. [Q7Z6L0-2]
DR   RefSeq; XP_016878377.1; XM_017022888.1. [Q7Z6L0-1]
DR   UniGene; Hs.655071; -.
DR   ProteinModelPortal; Q7Z6L0; -.
DR   BioGrid; 125188; 9.
DR   IntAct; Q7Z6L0; 2.
DR   MINT; MINT-1420001; -.
DR   STRING; 9606.ENSP00000351608; -.
DR   TCDB; 8.A.58.2.1; the dispanin (dispanin) family.
DR   iPTMnet; Q7Z6L0; -.
DR   PhosphoSitePlus; Q7Z6L0; -.
DR   BioMuta; PRRT2; -.
DR   DMDM; 74738828; -.
DR   PaxDb; Q7Z6L0; -.
DR   PeptideAtlas; Q7Z6L0; -.
DR   PRIDE; Q7Z6L0; -.
DR   DNASU; 112476; -.
DR   Ensembl; ENST00000300797; ENSP00000300797; ENSG00000167371. [Q7Z6L0-3]
DR   Ensembl; ENST00000358758; ENSP00000351608; ENSG00000167371. [Q7Z6L0-1]
DR   Ensembl; ENST00000567659; ENSP00000456226; ENSG00000167371. [Q7Z6L0-2]
DR   Ensembl; ENST00000572820; ENSP00000458291; ENSG00000167371. [Q7Z6L0-1]
DR   Ensembl; ENST00000636131; ENSP00000490390; ENSG00000167371. [Q7Z6L0-3]
DR   Ensembl; ENST00000637064; ENSP00000490826; ENSG00000167371. [Q7Z6L0-1]
DR   GeneID; 112476; -.
DR   KEGG; hsa:112476; -.
DR   UCSC; uc002dud.4; human. [Q7Z6L0-1]
DR   CTD; 112476; -.
DR   DisGeNET; 112476; -.
DR   GeneCards; PRRT2; -.
DR   GeneReviews; PRRT2; -.
DR   H-InvDB; HIX0012947; -.
DR   HGNC; HGNC:30500; PRRT2.
DR   HPA; HPA014447; -.
DR   HPA; HPA019203; -.
DR   MalaCards; PRRT2; -.
DR   MIM; 128200; phenotype.
DR   MIM; 602066; phenotype.
DR   MIM; 605751; phenotype.
DR   MIM; 614386; gene.
DR   neXtProt; NX_Q7Z6L0; -.
DR   OpenTargets; ENSG00000167371; -.
DR   Orphanet; 306; Benign familial infantile epilepsy.
DR   Orphanet; 569; Familial or sporadic hemiplegic migraine.
DR   Orphanet; 31709; Infantile convulsions and choreoathetosis.
DR   Orphanet; 98811; Paroxysmal exertion-induced dyskinesia.
DR   Orphanet; 98809; Paroxysmal kinesigenic dyskinesia.
DR   Orphanet; 98810; Paroxysmal non-kinesigenic dyskinesia.
DR   PharmGKB; PA142671132; -.
DR   eggNOG; ENOG410J12U; Eukaryota.
DR   eggNOG; ENOG410YRJ7; LUCA.
DR   GeneTree; ENSGT00530000063980; -.
DR   HOGENOM; HOG000115721; -.
DR   HOVERGEN; HBG097184; -.
DR   InParanoid; Q7Z6L0; -.
DR   OMA; TQKPRDY; -.
DR   OrthoDB; EOG091G0JH3; -.
DR   PhylomeDB; Q7Z6L0; -.
DR   TreeFam; TF331357; -.
DR   SignaLink; Q7Z6L0; -.
DR   GeneWiki; PRRT2; -.
DR   GenomeRNAi; 112476; -.
DR   PRO; PR:Q7Z6L0; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000167371; -.
DR   CleanEx; HS_PRRT2; -.
DR   ExpressionAtlas; Q7Z6L0; baseline and differential.
DR   Genevisible; Q7Z6L0; HS.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0045202; C:synapse; IEA:UniProtKB-SubCell.
DR   GO; GO:0050884; P:neuromuscular process controlling posture; IMP:MGI.
DR   GO; GO:0009607; P:response to biotic stimulus; IEA:InterPro.
DR   InterPro; IPR007593; CD225/Dispanin_fam.
DR   Pfam; PF04505; CD225; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell junction; Cell membrane; Complete proteome;
KW   Disease mutation; Dystonia; Epilepsy; Glycoprotein; Membrane;
KW   Methylation; Phosphoprotein; Polymorphism; Reference proteome;
KW   Synapse; Transmembrane; Transmembrane helix.
FT   CHAIN         1    340       Proline-rich transmembrane protein 2.
FT                                /FTId=PRO_0000307745.
FT   TOPO_DOM      1    268       Extracellular. {ECO:0000255}.
FT   TRANSMEM    269    289       Helical. {ECO:0000255}.
FT   TOPO_DOM    290    317       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    318    338       Helical. {ECO:0000255}.
FT   TOPO_DOM    339    340       Extracellular. {ECO:0000255}.
FT   COMPBIAS    131    216       Pro-rich.
FT   MOD_RES      28     28       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:E9PUL5}.
FT   MOD_RES      74     74       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:E9PUL5}.
FT   MOD_RES     238    238       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:D3ZFB6}.
FT   MOD_RES     240    240       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:E9PUL5}.
FT   MOD_RES     248    248       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:E9PUL5}.
FT   MOD_RES     249    249       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:E9PUL5}.
FT   CARBOHYD     53     53       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     294    340       SRNSLQQGDVDGAQRLGRVAKLLSIVALVGGVLIIIASCVI
FT                                NLGVYK -> VSPMGP (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_028814.
FT   VAR_SEQ     337    337       G -> GGEWGLGTGRGGMEGLARAALLTPAPALSCLSSLPL
FT                                LCLSLSPPPPVCPSLSSPT (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:16303743}.
FT                                /FTId=VSP_028815.
FT   VARIANT     138    138       P -> A (in dbSNP:rs79182085).
FT                                {ECO:0000269|PubMed:22101681}.
FT                                /FTId=VAR_067010.
FT   VARIANT     147    147       D -> H (in dbSNP:rs79568162).
FT                                {ECO:0000269|PubMed:22101681}.
FT                                /FTId=VAR_067011.
FT   VARIANT     214    214       A -> P (in dbSNP:rs745594874).
FT                                {ECO:0000269|PubMed:22101681}.
FT                                /FTId=VAR_067012.
FT   VARIANT     215    215       P -> R (in dbSNP:rs200926711).
FT                                {ECO:0000269|PubMed:22243967}.
FT                                /FTId=VAR_067320.
FT   VARIANT     216    216       P -> L (in dbSNP:rs76335820).
FT                                {ECO:0000269|PubMed:22243967}.
FT                                /FTId=VAR_067321.
FT   VARIANT     237    237       G -> R (in dbSNP:rs199556853).
FT                                {ECO:0000269|PubMed:22101681}.
FT                                /FTId=VAR_067013.
FT   VARIANT     245    245       R -> H (in dbSNP:rs754897123).
FT                                {ECO:0000269|PubMed:22101681}.
FT                                /FTId=VAR_067014.
FT   VARIANT     266    266       R -> W (in EKD1; dbSNP:rs387907128).
FT                                {ECO:0000269|PubMed:22120146}.
FT                                /FTId=VAR_067322.
FT   VARIANT     281    281       W -> R (in EKD1).
FT                                {ECO:0000269|PubMed:22131361}.
FT                                /FTId=VAR_067323.
FT   VARIANT     287    287       A -> T (in EKD1).
FT                                {ECO:0000269|PubMed:22131361}.
FT                                /FTId=VAR_067324.
FT   VARIANT     305    305       G -> R (in EKD1; dbSNP:rs767799831).
FT                                {ECO:0000269|PubMed:22209761}.
FT                                /FTId=VAR_067325.
FT   VARIANT     308    308       R -> C (in EKD1).
FT                                {ECO:0000269|PubMed:22131361}.
FT                                /FTId=VAR_067326.
FT   VARIANT     317    317       S -> N (in ICCA; dbSNP:rs387907125).
FT                                {ECO:0000269|PubMed:22243967}.
FT                                /FTId=VAR_067327.
FT   VARIANT     323    323       G -> E (in BFIS2).
FT                                {ECO:0000269|PubMed:22623405}.
FT                                /FTId=VAR_068426.
FT   CONFLICT    151    151       T -> S (in Ref. 5; AAH11405).
FT                                {ECO:0000305}.
FT   CONFLICT    214    214       A -> AP (in Ref. 3; CAD38881).
FT                                {ECO:0000305}.
FT   CONFLICT    275    275       S -> P (in Ref. 3; CAD38881).
FT                                {ECO:0000305}.
SQ   SEQUENCE   340 AA;  34945 MW;  F4BBA6559F081E34 CRC64;
     MAASSSEISE MKGVEESPKV PGEGPGHSEA ETGPPQVLAG VPDQPEAPQP GPNTTAAPVD
     SGPKAGLAPE TTETPAGASE TAQATDLSLS PGGESKANCS PEDPCQETVS KPEVSKEATA
     DQGSRLESAA PPEPAPEPAP QPDPRPDSQP TPKPALQPEL PTQEDPTPEI LSESVGEKQE
     NGAVVPLQAG DGEEGPAPEP HSPPSKKSPP ANGAPPRVLQ QLVEEDRMRR AHSGHPGSPR
     GSLSRHPSSQ LAGPGVEGGE GTQKPRDYII LAILSCFCPM WPVNIVAFAY AVMSRNSLQQ
     GDVDGAQRLG RVAKLLSIVA LVGGVLIIIA SCVINLGVYK
//
